The incidence of Ductal Carcinoma in Situ (DCIS) has increased dramatically in parallel with widespread implementation of screening mammography and comprises today about 20% of newly diagnosed breast cancers. These non-invasive breast tumors are heterogeneous and many will never progress to invasive cancer.
In an article published in npj Breast Cancer 17. June 2020, Helga Bergholtz, Tonje Lien and colleagues...
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet published in the Journal of Hepatology. The risk of liver cirrhosis increases if the levels of this biomarker rise between two testing occasions.
Fat accumulation in the liver is common and...
A robot that can measure the body temperature of people, for example in the waiting rooms of the hospital, is under development by researchers at Umeå University and the University Hospital of Umeå.
Text: Mikael Hansson
“We have previously used infrared cameras in our research on driverless forest vehicles, as a way of detecting people and avoiding collisions. Now we combine that...
An accumulation of an unexpected intermediate of the peptidoglycan recycling pathway that is able to modulate the synthesis and structure of the cell wall, has been found by researchers at Umeå University.
Most bacteria are shielded by a protective cell wall consisting of a strong yet elastic polymer called peptidoglycan. Peptidoglycan is essential for bacteria and so, it has always...
In a recent paper in Nature Cell Biology, an international team led by scientists at Institute for Cancer Research and Institute of Basic Medical Sciences shows that uncontrolled repair of micronuclear membranes causes chromosome shattering associated with cancer.
Senior scientist Marina Vietri and her co-workers at Institute for Cancer Research have previously identified a molecular mechanism for sealing holes in...
The company Jaisy from STING Incubator, Stockholm, Sweden has developed a low cost but highly accurate solution for non-invasive jaundice detection and measurement .Their solution is a cost effective non-invasive device with the ability to be widely spread and used by any clinic in the world and also affordable by any rural community and private individuals.
https://www.jaisyhealth.com
The company BioReperia from LEAD Inkubator, Linköping, Sweden, offers a humanized sebra-fish model for precision medicine. Many drugs fail at late stages of development due to efficacy or toxicity issues. The BioReperia model can be used to determine the efficiacy or toxicity of a drug candidate.
www.bioreperia.com
The company Alzinova AB from GU Innovation, Gothenburg, Sweden, conducts research and development of a long acting drug for treatment and prevention of Alzheimer´s disease. The company has a patented technology, a proprietary AβCC peptide™, that enables Alzinova to explore novel therapeutic strategies and develop research tools that enhance productivity within Alzheimer's disease research.
http://www.alzinova.com
The company CMRadiology from Karolinska Innovation, Stockholm, Sweden. with their service Collective Minds Radiology® is a cloud-based radiology service for collaboration decision support and consultations, based on the combination of human- and artificial intelligence. With CMRadiology, professionals around the world can share cases with other experts and build personal reference libraries.
https://www.cmrad.com
Dossier from Norway offers a complete learning environment that organizes and documents learning, skills and experience effectively, ensuring operational quality and patient safety. This includes On-the-Job-Training, procedures, e-learning and certifications, as well as end-user introductions to complex digital solutions like EMR/HER and medical devices. The company assist more than 350 000 healthcare professionals across the Nordics in reducing time spent...
- Advertisement -
- Advertisement -
- Advertisement -
